The ‘Rule of Three’: How the FDA is Hacking Drug Prices

The US Food and Drug Administration (FDA) is enforcing a policy called the ‘Rule of Three’ in an attempt to reduce pharmaceutical prices. The rule mandates that at least three manufacturers must produce a given drug to encourage competition and push drug prices down. The FDA is using tactics such as fast-tracking approvals, offering incentives, and monitoring compliance to ensure it is being followed.